Xilio Therapeutics, Inc.
USD9.44
+0.17 (+1.83%)
CEO
Rene Russo
IPO Date
2021-10-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.27
Prev. Close
$9.27
Day Low
$9.01
Day High
$9.45
52W Low
$6.47
52W High
$12.74
Market Cap
$0.06B
Volume
0.00M
| -0.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -207.5% | -125.4% | 0.31 | 3.02 | -0.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -83.5% | -63.4% | 0.19 | 5.89 | -0.8 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -40.9% | -34.2% | 0.11 | 15.85 | -1.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 1044.8% | -152.0% | -4.14 | 0.93 | -0.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -45.0% | -27.6% | 0.48 | 9.81 | -0.4 |
| 18.1 |
| 30 Sept 2025 | Q3 | 100.0% | -85.4% | 201.2% | -12.2% | -0.90 | 2.20 | -1.9 |
| 30 Jun 2025 | Q2 | -89.6% | -196.0% | -224.1% | -11.8% | 1.07 | 2.32 | -0.6 |
| 31 Mar 2025 | Q1 | 100.0% | -452.7% | -124.0% | -12.8% | 0.73 | 1.96 | -1.0 |
| 31 Dec 2024 | Q4 | 100.0% | -759.5% | -74.4% | -18.4% | 0.46 | 2.21 | -1.2 |
| 30 Sept 2024 | Q3 | 100.0% | -619.5% | -66.8% | -18.8% | 0.40 | 1.67 | -0.9 |
| 30 Jun 2024 | Q2 | 100.0% | -590.8% | -41.7% | -15.5% | 0.26 | 2.02 | -0.7 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -66.8% | -20.8% | 0.35 | 2.19 | -0.6 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -47.9% | -29.0% | 0.31 | 3.02 | -0.2 |